Our NIHR Guy’s and St Thomas’ Biomedical Research Centre Director, Professor Robin Ali, has been appointed as the Director of King’s College London’s newly renamed Centre for Gene Therapy and Regenerative Medicine (CGTRM).
The Centre acts as a focus for cutting-edge gene therapy and regenerative medicine research taking place across King’s College London and its partner NHS Trusts across King’s Health Partners. The Centre has broad expertise in gene therapy and stem cell technologies and brings together researchers who are developing advanced therapies for a range of conditions, including retinal disorders, diabetes, skin fibrosis and acute liver failure. It also features the ‘Stem Cell Hotel’, which provides dedicated laboratory space for collaborative studies of genotype/phenotype interactions in cells from healthy individuals and disease cohorts.
Professor Ali’s appointment to CGTRM will facilitate strategic oversight of the translational pipeline of advanced therapies across our NIHR BRC partnership, from bench to bedside, via the BRC’s Advanced Therapies Accelerator.
Commenting on Professor Ali’s appointment, Professor Charles Wolfe, Director of R&D at Guy’s and St Thomas’, said: “Robin’s appointment to CGTRM offers opportunities for faster translation of cell and gene therapies. The synergy between CGTRM and our Advanced Therapies Accelerator will enable quicker delivery of therapies to patients within our NIHR MHRA Phase I accredited Clinical Research Facility at Guy’s and St Thomas’.”
Professor Ali added: “The strengthened connection between CGTRM and our Biomedical Research Centre really increases the potential for developing therapies for patients with hard-to-treat conditions. I’m very much looking forward to working together with colleagues to ensure a new range of advanced therapies enter the clinic.”